In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

秒速赛车计划网页 排列三最大遗漏值尾 手机棋牌捕鱼游戏价格 安徽十一选五前三值走势图带连线 福建麻将怎么打16个牌 极速彩金捕鱼攻略 正版豪利棋牌网址是多少 球探篮球比分 北京pk拾手机app排行 温州麻将规则技巧 山西快乐十分胆拖价格表 河北20选5胆托投注金额计算表 1月7日cba比分